Objective: To clarify and elucidate the real correlation between tranexamic acid administration and post-operative bleeding parameters in high tibial osteotomy (HTO) patients. Material and Methods: Articles published in PubMed, Embase, and Cochrane Library were searched and included in our analysis under the eligibility criteria. Information related to bleeding parameters among HTO patients treated with tranexamic acid and placebo was collected and analyzed using random or fixed-effect models. Results: A total of five papers were included in our study. Our pooled calculations found that tranexamic acid was associated with reduced bleeding parameters in HTO patients including drainage volume on the first day (mean diff=1.47 [95% CI=0.33-2.65], p=0.0120), hemoglobin decline on the second day (mean diff=0.79 [95% CI=0.59-1.00], p=0.0000), and total blood loss (mean diff=2.25 [95% CI=0.59-3.91], p=0.0080) compared to control group. However, we failed to elucidate the correlation between tranexamic acid administration and hemoglobin decline on the first day among patients with HTO. Conclusion: Tranexamic acid is associated with reduced drainage volume on the first day, hemoglobin decline on the second day, and total blood loss among HTO patients.
Keywords: High tibial osteotomy; tranexamic acid; bleeding
Amaç: Yüksek tibial osteotomi (YTO) hastalarında traneksamik asit uygulaması ile ameliyat sonrası kanama parametreleri arasındaki gerçek korelasyonu netleştirmek ve aydınlatmak. Gereç ve Yöntemler: PubMed, Embase ve Cochrane Kütüphanesinde yayınlanan makaleler taranmış ve uygunluk kriterleri kapsamında araştırmamıza dahil edilmiştir. Traneksamik asit ve plasebo ile tedavi edilen YTO hastalarında kanama parametreleriyle ilgili bilgiler toplanmış ve rastgele veya sabit etkili modeller kullanılarak analiz edilmiştir. Bulgular: Çalışmamıza toplam beş makale dahil edilmiştir. Havuzlanmış hesaplamalarımıza göre traneksamik asidin kontrol grubuna göre YTO hastalarında kanama parametrelerinde azalma ile ilişkili olduğu bulunmuştur; ilk gündeki drenaj hacmi (ortalama fark = 1.47 [% 95 CI = 0.33-2.65], p = 0.0120), ikinci gün hemoglobin düşüşü (ortalama fark = 0.79 [% 95 CI = 0.59-1.00], p = 0.0000) ve toplam kan kaybı (ortalama fark = 2.25 [95% CI = 0.59-3.91], p = 0.0080). Bununla birlikte, YTO'lu hastalarda traneksamik asit uygulaması ile hemoglobinde ilk günkü düşüş arasındaki ilişkiyi aydınlatamadık. Sonuç: Traneksamik asit YTO hastalarında ilk gün azalmış drenaj hacmi, ikinci gün hemoglobin azalması ve toplam kan kaybı ile ilişkilidir.
Anahtar Kelimeler: Yüksek tibial osteotomi; traneksamik asit; kanama
- Wright JM, Crockett HC, Slawski DP, Madsen MW, Windsor RE. High tibial osteotomy. J Am Acad Orthop Surg. 2005;13(4):279-89.[Crossref] [PubMed]
- Spahn G. Complications in high tibial (medial opening wedge) osteotomy. Arch Orthop Trauma Surg. 2004;124(10):649-53.[Crossref] [PubMed]
- Georgoulis A, Makris C, Papageorgiou C, Moebius U, Xenakis T, Soucacos P. Nerve and vessel injuries during high tibial osteotomy combined with distal fibular osteotomy: a clinically relevant anatomic study. Knee Surgery, Sports Traumatology, Arthroscopy. 1999;7(1):15-9.[Crossref] [PubMed]
- Zhu JW, Chen DS, Wang TF, Xie Y. Patient characteristics related to blood loss in high tibial osteotomy in novel multiple linear regression analysis. Biomed Res Int. 2020;1;2020:8965925.[Crossref] [PubMed] [PMC]
- Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57(6):1005-32.[Crossref] [PubMed]
- Gausden EB, Qudsi R, Boone MD, OʼGara B, Ruzbarsky JJ, Lorich DG, et al. Tranexamic acid in orthopaedic trauma surgery: a meta-analysis. J Orthop Trauma. 2017;31(10):513-9.[PubMed] [PMC]
- Franchini M, Mengoli C, Marietta M, Marano G, Vaglio S, Pupella S, et al. Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials. Blood Transfus. 2018;16(1):36-43.[PubMed] [PMC]
- Yao RZ, Gao WQ, Wang BW, Wang GL, Wu CX, A-Mu YD, et al. Efficacy and safety of tranexamic acid in reducing blood loss of lower extremity osteotomy in peri-acetabulum and high tibia: a systematic review and meta-analysis. Orthop Surg. 2019;11(4):545-51.[Crossref] [PubMed] [PMC]
- Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;2;350:g7647. Erratum in: BMJ. 2016;21;354:i4086.[Crossref] [PubMed]
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-5.[Crossref] [PubMed]
- Ni J, Liu J, Zhang J, Jiang J, Dang X, Shi Z, et al. Tranexamic acid is beneficial for blood management of high tibial osteotomy: a randomized controlled study. Arch Orthop Trauma Surg. 2020:26.[Crossref] [PubMed]
- Palanisamy JV, Das S, Moon KH, Kim DH, Kim TK. Intravenous tranexamic acid reduces postoperative blood loss after high tibial osteotomy. Clin Orthop Relat Res. 2018;476(11):2148-54.[Crossref] [PubMed] [PMC]
- Kim KI, Kim HJ, Kim GB, Bae SH. Tranexamic acid is effective for blood management in open-wedge high tibial osteotomy. Orthop Traumatol Surg Res. 2018;104(7):1003-7.[Crossref] [PubMed]
- Suh DW, Kyung BS, Han SB, Cheong K, Lee WH. Efficacy of Tranexamic acid for hemostasis in patients undergoing high tibial osteotomy. J Knee Surg. 2018;31(1):50-5.[PubMed]
- Chen DS, Zhu JW, Wang TF, Zhu B, Feng CH. Tranexamic acid is beneficial to patients undergoing open-wedge high tibial osteotomy. Biomed Res Int. 2020;4;2020:2514207.[Crossref] [PubMed] [PMC]
- Zhu Q, Yu C, Chen X, Xu X, Chen Y, Liu C, et al. Efficacy and safety of tranexamic acid for blood salvage in intertrochanteric fracture surgery: a meta-analysis. Clin Appl Thromb Hemost. 2018;24(8):1189-98.[Crossref] [PubMed] [PMC]
- Chauncey J, Wieters J. Tranexamic Acid. 1st ed. Treasure Island (FL): StatPearls Publishing; 2020.
.: Process List